hVIVO plc (AIM & Euronext: HVO), formerly known as Open Orphan plc, and a global leader in conducting human challenge clinical trials for infectious and respiratory disease products, has announced that its Annual Report and Accounts for the year ended 31 December 2022 and Notice of Annual General Meeting (AGM) will be sent to shareholders today.
The 2022 Annual Report and Accounts, the Notice of AGM, and the form of proxy can be downloaded from the company’s website, www.hvivo.com.
The AGM is scheduled to take place on 23 May 2023 at 11 am at the offices of DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF, United Kingdom.
